(Total Views: 527)
Posted On: 09/29/2022 5:00:38 PM
Post# of 148902
Re: USS JOHNSTON #129065
This is the result of Regenxbio filing a lawsuit involving a clinical hold. Interestingly their drug is anti-VEGF which leronlimab also downregulates.
https://www.biopharmadive.com/news/regenxbio-...md/567049/
Quote:
Biotechnology company persuades FDA to lift clinical hold on experimental gene therapy
https://www.biopharmadive.com/news/regenxbio-...md/567049/
https://www.biopharmadive.com/news/regenxbio-...md/567049/
(4)
(0)Scroll down for more posts ▼
